文献速递消化、代谢与肾脏急症呼吸衰竭与机械通气重症综合管理与镇静镇痛

美国退伍军人事务部医疗系统中长新冠诊断编码的记录率及相关因素

Rates and Factors Associated With Documentation of Diagnostic Codes for Long COVID in the National Veterans Affairs Health Care System.
PubMed 文献 · JAMA Netw Open · 2022-07-01
一句话结论在198601例SARS-CoV-2阳性退伍军人中,仅13.5%在急性感染3个月后记录了长新冠相关诊疗编码,接种疫苗者记录率更低(AOR 0.78)。

这项回顾性队列研究利用美国退伍军人事务部医疗系统数据,纳入2020年2月1日至2021年4月30日SARS-CoV-2检测阳性、感染后3个月仍存活且无再感染证据的198601例患者。平均随访13.5个月期间,13.5%的患者记录了长新冠相关ICD-10编码,最常见于初级保健/普通内科(33.1%)、肺科(13.1%)和老年科(9.7%)。记录率在地理区域(10.8%-18.1%)和医疗中心(3.0%-41.0%)间差异很大;高龄、黑人/美洲印第安人/阿拉斯加原住民、西班牙裔、高Charlson合并症指数、急性期有症状(AOR 1.71)、需住院(AOR 2.60)或机械通气(AOR 2.46)与记录率升高相关,感染时完全接种疫苗者记录率较低(AOR 0.78)。作者认为这些发现为医疗系统系统化评估和管理长新冠患者提供了支持与指导。

要点

  • 198601例SARS-CoV-2阳性者中,仅26745例(13.5%)在感染3个月后记录了长新冠相关诊疗编码。
  • 长新冠诊疗记录最常见于初级保健/普通内科(18634/56310次就诊,33.1%)、肺科(13.1%)和老年科(9.7%)。
  • 记录率在地理区域间为10.8%-18.1%,在医疗中心间为3.0%-41.0%,差异很大。
  • 急性期需住院者长新冠记录率更高(AOR 2.60;95%CI 2.51-2.69),需机械通气者AOR 2.46(95%CI 2.26-2.69)。
  • 感染时已完全接种疫苗者长新冠记录率较低(AOR 0.78;95%CI 0.68-0.90)。

适用人群与场景

  • 美国退伍军人事务部医疗系统中2020年2月1日至2021年4月30日SARS-CoV-2检测阳性、感染后3个月仍存活且无再感染证据者,共198601例;平均(SD)年龄60.4(17.7)岁,男性176942例(89.1%),白人133924例(67.4%),黑人44733例(22.5%),西班牙裔19735例(9.9%)。

诊断标准与关键阈值

  • 长新冠诊疗记录定义为急性感染3个月后记录COVID-19相关ICD-10编码:U07.1、Z86.16、U09.9和J12.82。

研究设计与关键结果

  • 研究类型:回顾性队列研究,使用美国退伍军人事务部医疗系统数据,纳入198601例SARS-CoV-2阳性者,随访至2021年12月31日,平均(SD)随访13.5(3.6)个月。
  • 长新冠诊疗记录见于26745例(13.5%),分布于多种门诊,最常见于初级保健/普通内科(18634/56310次就诊,33.1%)、肺科(7360/56310,13.1%)和老年科(5454/56310,9.7%)。
  • 长新冠记录率在地理区域间为10.8%-18.1%,在医疗中心间为3.0%-41.0%。
  • 与长新冠记录显著相关的因素包括高龄、黑人/美洲印第安人/阿拉斯加原住民、西班牙裔、地理区域、高Charlson合并症指数、急性感染时有症状(AOR 1.71;95%CI 1.65-1.78)、需住院(AOR 2.60;95%CI 2.51-2.69)或机械通气(AOR 2.46;95%CI 2.26-2.69)。
  • 感染时已完全接种疫苗者接受长新冠诊疗记录的可能性较低(AOR 0.78;95%CI 0.68-0.90)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些发现为医疗系统制定系统化方法以评估和管理可能出现长新冠的患者提供了支持与指导。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Some persons infected with SARS-CoV-2 experience symptoms or impairments many months after acute infection.

OBJECTIVES: To determine the rates, clinical setting, and factors associated with documented receipt of COVID-19-related care 3 or more months after acute infection.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used data from the US Department of Veterans Affairs health care system. Participants included persons with a positive SARS-CoV-2 test between February 1, 2020, and April 30, 2021, who were still alive 3 months after infection and did not have evidence of reinfection. Data analysis was performed from February 2020 to December 2021.

EXPOSURES: Positive SARS-CoV-2 test.

MAIN OUTCOMES AND MEASURES: Rates and factors associated with documentation of COVID-19-related International Statistical Classification of Diseases and Related Health Problems, Tenth Revision codes (U07.1, Z86.16, U09.9, and J12.82) 3 or more months after acute infection (hereafter, long-COVID care), with follow-up extending to December 31, 2021.

RESULTS: Among 198 601 SARS-CoV-2-positive persons included in the study, the mean (SD) age was 60.4 (17.7) years, 176 942 individuals (89.1%) were male, 133 924 (67.4%) were White, 44 733 (22.5%) were Black, and 19 735 (9.9%) were Hispanic. During a mean (SD) follow-up of 13.5 (3.6) months, long-COVID care was documented in a wide variety of clinics, most commonly primary care and general internal medicine (18 634 of 56 310 encounters [33.1%]), pulmonary (7360 of 56 310 encounters [13.1%]), and geriatrics (5454 of 56 310 encounters [9.7%]). Long-COVID care was documented in 26 745 cohort members (13.5%), with great variability across geographical regions (range, 10.8%-18.1%) and medical centers (range, 3.0%-41.0%). Factors significantly associated with documented long-COVID care included older age, Black or American Indian/Alaska Native race, Hispanic ethnicity, geographical region, high Charlson Comorbidity Index score, having documented symptoms at the time of acute infection (adjusted odds ratio [AOR], 1.71; 95% CI, 1.65-1.78) and requiring hospitalization (AOR, 2.60; 95% CI, 2.51-2.69) or mechanical ventilation (AOR, 2.46; 95% CI, 2.26-2.69). Patients who were fully vaccinated at the time of infection were less likely to receive long-COVID care (AOR, 0.78; 95% CI, 0.68-0.90).

CONCLUSIONS AND RELEVANCE: Long-COVID care was documented in a variety of clinical settings, with great variability across regions and medical centers and was documented more commonly in older persons, those with higher comorbidity burden, those with more severe acute COVID-19 presentation and those who were unvaccinated at the time of infection. These findings provide support and guidance for health care systems to develop systematic approaches to the evaluation and management of patients who may be experiencing long COVID.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Ioannou GN, Baraff A, Fox A, et al. Rates and Factors Associated With Documentation of Diagnostic Codes for Long COVID in the National Veterans Affairs Health Care System. JAMA Netw Open. 2022. PMID: 35904783. doi:10.1001/jamanetworkopen.2022.24359

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。